Breaking out: Improving economy will raise demand for name-brand drugs, boosting revenue

IBISWorld’s industry research report on Cold Sore Medication Manufacturing contains five-year forecasts and data analysis that can help you identify and mitigate risks in potential new markets. Position yourself as an expert with internal stakeholders by using our comprehensive industry research to inform your reports, proposals and presentations. Our business information will save you money by helping you make better decisions, faster.


Industry Threats & Opportunities

  • An increase in the popularity of generic cold sore medications has reduced industry revenue
  • Industry revenue increased as private and public insurance coverage expanded
  • As the economy gains steam, consumers will increasingly switch from generic to premium brands

  • shopping_cartBUY NOW TO READ MORE

    Industry Analysis & Industry Trends

    Over the five years to 2016, the Cold Sore Medication Manufacturing industry has experienced slow but stable growth. Falling unemployment, rising per capita disposable income and the expansion of healthcare coverage have made consumers better able to afford industry products. Meanwhile, since the elderly are more susceptible to cold sore outbreaks, the aging of the population has further boosted demand for industry medications. However, since the expirations of patents on some of the industry's name-brand medications, competition from discount generics has eroded revenue...

    shopping_cartBUY NOW TO READ MORE

    Industry Report - Industry Key Buyers Chapter

    The Cold Sore Medication Manufacturing industry is highly concentrated. GlaxoSmithKline and Novartis AG, the industry's two largest companies, are expected to generate roughly 75.0% of total industry revenue in 2016. Despite this, patent expirations and sales declines of industry leading product lines such as Valtrex and Famvir have opened the door to generic drug manufacturers who have quickly taken market share at the expense of the major players. Despite this, industry leader GlaxoSmithKline still controls an estimated 56.9% of industry revenue with its group of leading industry product lines, including Valtrex and Abreva. Novartis also still controls an estimated 17.8% market share due to brand name and generic sales of its cold sore medication product Famvir.


    shopping_cartBUY NOW TO READ MORE

    Additional Insights for the Cold Sore Medication Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the Cold Sore Medication Manufacturing Industry are

  • Undertaking pharmaceutical and medicine R&D
  • Establishment of brand names
  • Degree of globalization in the firm
  • IBISWorld analysts also discuss how external factors such as Per capita disposable income and Median age of population in the Cold Sore Medication Manufacturing industry impact industry performance..

    shopping_cartBUY NOW TO READ MORE

    Look under the hood?

    Download a FREE sample report

    Industry Products

    What is the Cold Sore Medication Manufacturing Industry?

    This industry develops and produces over-the-counter (OTC) and prescription treatments for cold sores, which are inflamed blisters in or near the mouth, caused by infection from the herpes simplex virus.

    Industry Products
    OTC medications and generics
    Topical prescription medications
    Oral prescription medications
    Industry Activities
    Manufacturing over-the-counter (OTC) cold sore medication
    Manufacturing prescription cold sore medication
    Developing cold sore medication

    Table of Contents

    About this Industry
    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry at a Glance
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Industry Performance
    Executive Summary
    Key External Drivers
  • Per capita disposable income
  • Median age of population
  • Research and development expenditure
  • Total health expenditure
  • Trade-weighted index

  • Current Performance
    Demographic factorsEconomic trendsCompetition at home and abroad
  • Chart: Revenue Growth

  • Industry Outlook
    Demographics and economicsCompetition and expansion
  • Table: Cold Sore Medication Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - Cold Sore Medication Manufacturing Industry Lifecycle vs The Economy

  • Products & Markets
    Supply Chains
    Key Buying Industries
  • Drug, Cosmetic & Toiletry Wholesaling
  • Supermarkets & Grocery Stores
  • Pharmacies & Drug Stores
  • Health Stores
  • Hospitals

  • Key Selling Industries
  • Biotechnology
  • Chemical Product Manufacturing
  • Medical Device Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Oral prescription medications
  • OTC medications and generics
  • Topical prescription medications
  • Chart: Cold Sore Medication Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
  • Insurance a key determinant
  • Direct-to-consumer marketing
  • General economic conditions

  • Major Markets
  • Consumers aged 18 to 54
  • Consumers aged 55 and older
  • Consumers aged 17 and younger
  • Exports
  • Chart: Major Market Segmentation for the Cold Sore Medication Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Competitive Landscape
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
    ProfitWagesResearch and developmentPurchasesMarketingOther
  • Chart: Cost Structure Benchmarking – Sector vs Cold Sore Medication Manufacturing

  • Basis of Competition
  • Exclusivity times
  • Marketing ability and promotional spending

  • Barriers to Entry
  • Table: Barrier to Entry Checklist for the Cold Sore Medication Manufacturing Industry

  • Industry Globalization
    Major Companies
    GlaxoSmithKline PLCNovartis AG
  • Table: GlaxoSmithKline PLC - financial performance
  • Table: Novartis AG - financial performance

  • Operating Conditions
    Capital Intensity
  • Chart: Level of Capital Intensity for the Cold Sore Medication Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Key Statistics
    Table: Industry Data for the Cold Sore Medication Manufacturing Industry
  • Industry Revenue (2007-2021)
  • Industry Gross Product (2007-2021)
  • Establishments (2007-2021)
  • Businesses (2007-2021)
  • Employment (2007-2021)
  • Exports (2007-2021)
  • Imports (2007-2021)
  • Wages (2007-2021)
  • Healthcare expenditure (2007-2021)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Jargon & Glossary
  • Nonproprietary; denoting a drug name not protected by a trademark, usually descriptive of the drug's chemical structure.
  • Otc
  • Over the counter; medications not requiring a prescription.
  • Private Label Brands
  • Products developed and marketed by a retailer and only available for sale by that retailer. Also called store brands.
  • Topical
  • Designed for or involving application to or action on the surface of a part of the body.
  • Why buy this report?

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on Cold Sore Medication Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The Cold Sore Medication Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on Cold Sore Medication Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Join IBISWorld today

    Contact Us

    Want to speak to a representative? Call us.